• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    1.44 Up 0.07(5.11%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.37
    Open:1.38
    Bid:1.21 x 100
    Ask:1.45 x 1500
    1y Target Est:2.00
    Beta:1.27
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:1.38 - 1.45
    52wk Range:0.61 - 2.02
    Volume:512,052
    Avg Vol (3m):1,058,690
    Market Cap:74.61M
    P/E (ttm):N/A
    EPS (ttm):-1.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AVEO

    Comparison

    Symbol% ChgMkt Cap
    AVEOUp 5.11%74.61M
    AMGNUp 1.05%124.68B
    PFEUp 1.36%214.51B
    RHHBYDown 0.12%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.77
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:3.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. Its product candidates under development include Tivozanib, an tyrosine kinase inhibitor for various vascular endot... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback